Congress trades

Onconetix, Inc. (ONCO)

Biotechnology, listed on NASDAQ.

20 Congress tradeslast filed Nov 10, 2025

Download on the App StoreGet it on Google Play

Free on iOS and Android

EarningsScheduled · Nov 12, 2026

Onconetix reports Nov 12.

The date the company scheduled. A company can move it.

Last report: Q2 FY2026, Aug 13, 2026. In line on revenue.

Every quarter

CongressSTOCK Act disclosures to the House and Senate

19 Congress disclosures shown, from 4 members.

24dMedian delayof the 45 day limit
10 buys · 5 sellsPurchases and sales in the disclosures shown, excluding notes and bonds
Every Congress trade in ONCOEvery disclosure
Companyfrom the company's filings and listing, as of Nov 8, 2026

About Onconetix, Inc.

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Chief executive
David Allan White
Employees
2
Listed since
Feb 18, 2022
Market value
$2.5M
Price to earnings (12 mo)
-
Net income per share, as reported (12 mo)
-$45.46
Dividend yield
-

www.onconetix.com

Earnings6 reported quarters · next on Nov 12, 2026

Earnings

QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 13, 2026-$1.28n/a$17K$17KEPS n/aRevenue in line
Q1 FY2026reported May 13, 2026-$67.10n/a$21Kn/aEPS n/aRevenue n/a
Q4 FY2025reported Mar 13, 2026$10.40n/a$304Kn/aEPS n/aRevenue n/a
Q3 FY2025reported Nov 13, 2025-$312.50n/a$304Kn/aEPS n/aRevenue n/a
Q2 FY2025reported Aug 14, 2025-$202.50n/a$106Kn/aEPS n/aRevenue n/a
Q1 FY2025reported Jun 12, 2025-$1059.32n/a$102Kn/aEPS n/aRevenue n/a

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A figure or flag reads n/a when a number is missing, or when the figure failed our check against the company's other quarters, its own filings and its share splits, and was left out. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

STOCK Act19 disclosures of 20 on record · median 24d of the 45 allowed

Congress trades in ONCO

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Michael T. McCaulStockSale$1,001 - $15,000n/aOct 17, 2025Nov 10, 202524d
Michael T. McCaulStockPurchase$1,001 - $15,000n/aOct 11, 2023Nov 13, 202333d
Michael T. McCaulStockSale$100,001 - $250,000n/aAug 24, 2023Sep 14, 202321d
Michael T. McCaulStockPurchase$100,001 - $250,000n/aJul 14, 2023Aug 16, 202333d
Michael T. McCaulStockPurchase$100,001 - $250,000n/aApr 18, 2023May 12, 202324d
Charles J. "Chuck" FleischmannStockPurchase$1,001 - $15,000n/aApr 10, 2023May 9, 202329d
Ro KhannaStockPurchase$1,001 - $15,000n/aMar 14, 2023Apr 7, 202324d
Michael T. McCaulStockPurchase$100,001 - $250,000n/aJan 3, 2023Feb 15, 202343d
Ro KhannaStockPurchase$1,001 - $15,000n/aSep 29, 2022Oct 7, 20228d
Ro KhannaStockPurchase$1,001 - $15,000n/aJun 27, 2022Jul 7, 202210d
Ro KhannaNot shares: HONOLULU HAWAII CITY & CNTY REV 5.BondSale$15,001 - $50,000n/aJun 30, 2022Jul 7, 20227d
Diana HarshbargerStockPurchase$1,001 - $15,000n/aMay 16, 2022May 26, 202210d
Michael T. McCaulStockPurchase$100,001 - $250,000n/aJan 26, 2022Feb 23, 202228d
Michael T. McCaulNot shares: HONOLULU HAWAII CITY& CNTY GO BDSBondPurchase$1,001 - $15,000n/aJan 22, 2019Feb 25, 201934d
Michael T. McCaulStockSale$15,001 - $50,000n/aOct 24, 2018Nov 15, 201822d
Michael T. McCaulNot shares: HONOLULU HAWAII CITY& CNTY G O BDSBondPurchase$100,001 - $250,000n/aAug 28, 2018Sep 12, 201815d
Michael T. McCaulNot shares: HONOLULU HAWAII CITY& CNTY GO BDSBondPurchase$100,001 - $250,000n/aSep 6, 2018Sep 12, 20186d
Michael T. McCaulStockSale$1,001 - $15,000n/aDec 9, 2015Feb 3, 201656d
Michael T. McCaulStockSale$1,001 - $15,000n/aMar 6, 2014Apr 10, 201435d

We hold no closing prices for any row shown here, so no move is shown. Not investment advice.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in ONCO filterable by party, chamber, type and account.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.

Data as of Nov 9, 2026.

Methodology · Guide to Form 4 · Guide to the STOCK Act

Questions

What the filings on ONCO show and how current they are.

Which members of Congress have traded ONCO?

Michael T. McCaul, Charles J. "Chuck" Fleischmann, Ro Khanna and Diana Harshbarger disclosed ONCO transactions in the filings shown here.

How quickly are ONCO trades disclosed?

Congressional disclosures took a median of 24 days, against the 45 the STOCK Act allows.

Related companies

traded by the same members

See every company we track